Alvolab officially launches

We are excited to announce the official launch of Alvolab, a preclinical CRO dedicated to advancing kidney disease research through high-quality in vivo models and tissue analysis.

We specialize in experimental models of acute kidney injury, chronic kidney disease and diabetic nephropathy, combining biomarker, tissue and in vivo analysis to generate translational insights that matter. Our mission is simple: accelerate kidney research with scientific rigor and operational transparency.

Our first stop after launch: ERA 2025 in Vienna.